Difficulty: Medium
Average Score: 93%
Practice
During assessment, the patient mentions that he recently 'sent off to a company for pharmacogenomic testing.' What nursing responses are indicated?
Correct answer
A
Rationale
In the context of Pharmacology Across the Lifespan, understanding pharmacogenomics is crucial as it involves how an individual's genetic makeup influences their response to medications. The correct response, "A) Have you changed your medications any?" is the most appropriate because it directly addresses the potential impact of pharmacogenomic testing on the patient's medication regimen. By inquiring about medication changes, the nurse can assess if the patient has made any adjustments based on the test results.
Option B, "Have you talked with your physician about the results?" is not as ideal as it assumes the patient has already discussed the results with their physician. The nurse should first gather information about any changes made by the patient before recommending further action.
Option C, "Why did you do that?" lacks specificity and may come across as judgmental or intrusive. It does not address the immediate concern of medication changes post-testing.
Option D, "Was that test expensive?" is irrelevant to the patient's current medication management and does not contribute to a therapeutic conversation regarding the implications of pharmacogenomic testing.
In an educational context, nurses need to be equipped to understand and respond effectively to patients who have undergone pharmacogenomic testing. It is important to assess how this testing may impact drug therapy and patient outcomes, emphasizing the need for personalized medicine in pharmacological care. By addressing medication changes, nurses can ensure safe and individualized treatment plans tailored to each patient's genetic profile.
Option B, "Have you talked with your physician about the results?" is not as ideal as it assumes the patient has already discussed the results with their physician. The nurse should first gather information about any changes made by the patient before recommending further action.
Option C, "Why did you do that?" lacks specificity and may come across as judgmental or intrusive. It does not address the immediate concern of medication changes post-testing.
Option D, "Was that test expensive?" is irrelevant to the patient's current medication management and does not contribute to a therapeutic conversation regarding the implications of pharmacogenomic testing.
In an educational context, nurses need to be equipped to understand and respond effectively to patients who have undergone pharmacogenomic testing. It is important to assess how this testing may impact drug therapy and patient outcomes, emphasizing the need for personalized medicine in pharmacological care. By addressing medication changes, nurses can ensure safe and individualized treatment plans tailored to each patient's genetic profile.